Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort …
A Kästner, A Kron, N van den Berg, K Moon… - The Lancet Regional …, 2024 - thelancet.com
Summary Background The national Network Genomic Medicine (nNGM) Lung Cancer
provides comprehensive and high-quality multiplex molecular diagnostics and standardized …
provides comprehensive and high-quality multiplex molecular diagnostics and standardized …
[HTML][HTML] Promoting informed decision-making in a primary care practice by implementing decision aids
CL Lewis, MP Pignone - North Carolina medical journal, 2009 - ncbi.nlm.nih.gov
Empowering patients to be effective advocates for their health requires that they have
adequate information and understanding about their health conditions. Many patients have …
adequate information and understanding about their health conditions. Many patients have …
Big data for geriatric oncology research
ED Duchesneau, HD Klepin… - North Carolina …, 2024 - ncmedicaljournal.com
Cancer is the second leading cause of death in North Carolina and approximately half of
cancers are diagnosed in older adults (≥ 65 years). Cancer clinical trials in older adults are …
cancers are diagnosed in older adults (≥ 65 years). Cancer clinical trials in older adults are …
Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012–2018
A Wolf, JA Stratmann, S Shaid, N Niklas… - BMC Pulmonary …, 2023 - Springer
Abstract Background Immune checkpoint inhibitors (ICIs) have improved outcomes for
patients with advanced non-small cell lung cancer (NSCLC) versus chemotherapy in clinical …
patients with advanced non-small cell lung cancer (NSCLC) versus chemotherapy in clinical …
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type
Aims This study described treatment patterns, healthcare resource utilization (HRU) and
costs among advanced or metastatic non-small cell lung cancer (a/mNSCLC) patients with …
costs among advanced or metastatic non-small cell lung cancer (a/mNSCLC) patients with …
Validation of an Updated Algorithm to Identify Patients With Incident Non–Small Cell Lung Cancer in Administrative Claims Databases
PURPOSE Real-world lung cancer data in administrative claims databases often lack
staging information and specific diagnostic codes for lung cancer histology subtypes. This …
staging information and specific diagnostic codes for lung cancer histology subtypes. This …
Prediction of Lung Cancer from Electronic Health Records Using CNN Supported NLP
K Jabir, A Thirumurthi Raja - Computational Intelligence for Clinical …, 2023 - Springer
Lung tumors act as a severe cancer type across the globe, and it is common among both
men and women. With increasing medical and healthcare facilities, the contribution to …
men and women. With increasing medical and healthcare facilities, the contribution to …
Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012–2018
W Andrea, S Jan A, S Shabnam - 2023 - dlib.phenikaa-uni.edu.vn
Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with advanced non-
small cell lung cancer (NSCLC) versus chemotherapy in clinical trials. In Germany, ICIs have …
small cell lung cancer (NSCLC) versus chemotherapy in clinical trials. In Germany, ICIs have …